Vertex Pharmaceuticals
VRTX
#187
Rank
HK$945.55 B
Marketcap
HK$3,726
Share price
1.45%
Change (1 day)
5.42%
Change (1 year)

EPS for Vertex Pharmaceuticals (VRTX)

EPS in 2026 (TTM): HK$132.87

According to Vertex Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$133.36. In 2025 the company made an earnings per share (EPS) of HK$121.28 an increase over its 2024 EPS that were of -HK$16.15.

EPS history for Vertex Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$132.879.55%
2025HK$121.28-850.97%
2024-HK$16.15-114.67%
2023HK$110.078.17%
2022HK$101.7642.64%
2021HK$71.34-12.67%
2020HK$81.69128.01%
2019HK$35.83-44.54%
2018HK$64.60670.09%
2017HK$8.39-327.66%
2016-HK$3.68-79.65%
2015-HK$18.11-26.43%
2014-HK$24.6253.92%
2013-HK$15.99316.33%
2012-HK$3.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.49-48.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$16.12-87.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$53.70-59.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$27.89-79.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$27.91-79.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-HK$30.03-122.52%๐Ÿ‡บ๐Ÿ‡ธ USA